Healthcare Equipment and Supplies
Company Overview of InSightec Ltd.
InSightec Ltd. develops and distributes the Exablate platform that provides non-invasive treatments for various oncology and gynecology indications. The company offers a neurosurgery solution that includes Exablate Neuro, a non-invasive and image-guided personalized thalamotomy for movement disorders and pain, treated through an intact skull; MR guided Focused (MRgFUS), a non-invasive thermal ablation technique to relieve symptoms caused by uterine fibroids, as well as destroys uterine fibroid tissue using a thermal effect; and a non-invasive and non-ionizing treatment uses focused ultrasound waves to ablate the target treatment with minimal damage to surrounding tissues. It also provides on...
5 Nahum Heth Street
Tirat Carmel, 39120
Founded in 1999
Key Executives for InSightec Ltd.
Executive Chairman and Chief Executive Officer
President and Chief Commercial Officer
Founder and Vice Chairman
Chief Financial Officer and Vice President
Vice President of Operations and Quality
Compensation as of Fiscal Year 2015.
InSightec Ltd. Key Developments
INSIGHTEC Appoints Eyal Zadicario as General Manager
Jan 8 16
INSIGHTEC announced that Eyal Zadicario has been appointed General Manager of the company. Eyal will lead the company's Research and Development and Operations. Eyal has been involved in research and development of multidisciplinary advanced technology projects for more than 25 years. Eyal joined INSIGHTEC when it was founded in 1999, and in 2001, he became INSIGHTEC's Neuro Program Manager where he led the development of Exablate Neuro that received CE approval in 2012. The Exablate Neuro system is being evaluated for additional regulatory approvals and researched for new applications in Neuroscience.
InSightec Ltd. Announces Executive Changes
Dec 31 15
Elbit Medical Ltd. announced that it was informed by InSightec Ltd. that Dr. Kobi Vortman will terminate his position as the CEO of InSightec, and will become Vice Chairman of the Board, effective as of January 1, 2016, and Dr. Maurice Ferre will become CEO of InSightec effective as of the same date (in addition to serving as chairman of the Board).
InSightec Ltd. Submits Pre Market Application for FDA Approval of Exablate Neuro for Treatment of Essential Tremor
Oct 22 15
Elbit Imaging Ltd. announced that it was informed by InSightec's Ltd., that it has submitted a premarket approval application (PMA) to the U.S. Food and Drug Administration (FDA) for its Exablate Neuro treatment of Essential Tremor. Exablate Neuro uses high intensity focused ultrasound to thermally ablate the target tissue and continuous MRI to visualize the anatomy, plan treatment and monitor treatment outcomes. In the brain, MRgFUS is used to perform a non-invasive thalamotomy through intact skull to relieve tremor in patients with Essential Tremor.
Similar Private Companies By Industry
Recent Private Companies Transactions
December 31, 2015
May 25, 2015
Most Searched Private Companies
Sponsored Financial Commentaries